80 FR 17442 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration Federal Register Volume 80, Issue 62 (April 1, 2015)
Substance Abuse and Mental Health Services Administration
Federal Register Volume 80, Issue 62 (April 1, 2015)
| Page Range | 17442-17444 | |
| FR Document | 2015-07423 |
[Federal Register Volume 80, Number 62 (Wednesday, April 1, 2015)] [Notices] [Pages 17442-17444] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-07423] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies AGENCY: Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); and on April 30, 2010 (75 FR 22809). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at http://beta.samhsa.gov/workplace. FOR FURTHER INFORMATION CONTACT: Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, Room 7-1051, One Choke Cherry Road, Rockville, Maryland 20857; 240-276-2600 (voice), 240-276-2610 (fax). SUPPLEMENTARY INFORMATION: The Mandatory Guidelines were initially developed in accordance with Executive Order 12564 and section 503 of Pub. L. 100-71. The ``Mandatory Guidelines for Federal Workplace Drug Testing Programs,'' as amended in the revisions listed above, requires strict standards that laboratories and IITFs must meet in order to conduct drug and specimen validity tests on urine specimens for federal agencies. To become certified, an applicant laboratory or IITF must undergo three rounds of performance testing plus an on-site inspection. To maintain that certification, a laboratory or IITF must participate in a quarterly performance testing program plus undergo periodic, on-site inspections. Laboratories and IITFs in the applicant stage of certification are not to be considered as meeting the minimum requirements described in the HHS Mandatory Guidelines. A HHS-certified laboratory or IITF must have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA), which attests that it has met minimum standards. In accordance with the Mandatory Guidelines dated November 25, 2008 (73 FR 71858), the following HHS- [[Page 17443]] certified laboratories and IITFs meet the minimum standards to conduct drug and specimen validity tests on urine specimens: HHS-Certified Instrumented Initial Testing Facilities: Gamma-Dynacare Medical Laboratories 6628 50th Street NW. Edmonton, AB Canada T6B 2N7 780-784-1190 HHS-Certified Laboratories: ACM Medical Laboratory, Inc. 160 Elmgrove Park Rochester, NY 14624 585-429-2264 Aegis Analytical Laboratories, Inc. 345 Hill Ave. Nashville, TN 37210 615-255-2400 (Formerly: Aegis Sciences Corporation, Aegis Analytical Laboratories, Inc., Aegis Analytical Laboratories) Alere Toxicology Services 1111 Newton St. Gretna, LA 70053 504-361-8989/800-433-3823 (Formerly: Kroll Laboratory Specialists, Inc., Laboratory Specialists, Inc.) Alere Toxicology Services 450 Southlake Blvd. Richmond, VA 23236 804-378-9130 (Formerly: Kroll Laboratory Specialists, Inc., Scientific Testing Laboratories, Inc.; Kroll Scientific Testing Laboratories, Inc.) Baptist Medical Center-Toxicology Laboratory 11401 I-30 Little Rock, AR 72209-7056 501-202-2783 (Formerly: Forensic Toxicology Laboratory Baptist Medical Center) Clinical Reference Lab 8433 Quivira Road Lenexa, KS 66215-2802 800-445-6917 DrugScan, Inc. 200 Precision Road, Suite 200 Horsham, PA 19044 800-235-4890 ElSohly Laboratories, Inc. 5 Industrial Park Drive Oxford, MS 38655 662-236-2609 Fortes Laboratories, Inc. 25749 SW Canyon Creek Road, Suite 600 Wilsonville, OR 97070 503-486-1023 Gamma-Dynacare Medical Laboratories* A Division of the Gamma-Dynacare Laboratory Partnership 245 Pall Mall Street London, ONT, Canada N6A 1P4 519-679-1630 Laboratory Corporation of America Holdings 7207 N. Gessner Road Houston, TX 77040 713-856-8288/800-800-2387 Laboratory Corporation of America Holdings 69 First Ave. Raritan, NJ 08869 908-526-2400/800-437-4986 (Formerly: Roche Biomedical Laboratories, Inc.) Laboratory Corporation of America Holdings 1904 Alexander Drive Research Triangle Park, NC 27709 919-572-6900/800-833-3984 (Formerly: LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche Group) Laboratory Corporation of America Holdings 1120 Main Street Southaven, MS 38671 866-827-8042/800-233-6339 (Formerly: LabCorp Occupational Testing Services, Inc.; MedExpress/ National Laboratory Center) LabOne, Inc. d/b/a Quest Diagnostics 10101 Renner Blvd. Lenexa, KS 66219 913-888-3927/800-873-8845 (Formerly: Quest Diagnostics Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division of LabOne, Inc.) MedTox Laboratories, Inc. 402 W. County Road D St. Paul, MN 55112 651-636-7466/800-832-3244 MetroLab-Legacy Laboratory Services 1225 NE 2nd Ave. Portland, OR 97232 503-413-5295/800-950-5295 Minneapolis Veterans Affairs Medical Center Forensic Toxicology Laboratory 1 Veterans Drive Minneapolis, MN 55417 612-725-2088 National Toxicology Laboratories, Inc. 1100 California Ave. Bakersfield, CA 93304 661-322-4250/800-350-3515 One Source Toxicology Laboratory, Inc. 1213 Genoa-Red Bluff Pasadena, TX 77504 888-747-3774 (Formerly: University of Texas Medical Branch, Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory) Pacific Toxicology Laboratories 9348 DeSoto Ave. Chatsworth, CA 91311 800-328-6942 (Formerly: Centinela Hospital Airport Toxicology Laboratory) Pathology Associates Medical Laboratories 110 West Cliff Dr. Spokane, WA 99204 509-755-8991/800-541-7891x7 Phamatech, Inc. 15175 Innovation Drive San Diego, CA 92128 888-635-5840 Quest Diagnostics Incorporated 1777 Montreal Circle Tucker, GA 30084 800-729-6432 (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories) Quest Diagnostics Incorporated 400 Egypt Road Norristown, PA 19403 610-631-4600/877-642-2216 (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories) Quest Diagnostics Incorporated 8401 Fallbrook Ave. West Hills, CA 91304 818-737-6370 (Formerly: SmithKline Beecham Clinical Laboratories) Redwood Toxicology Laboratory 3700650 Westwind Blvd. Santa Rosa, CA 95403 800-255-2159 Southwest Laboratories 4625 E. Cotton Center Boulevard Suite 177 Phoenix, AZ 85040 602-438-8507/800-279-0027 STERLING Reference Laboratories 2617 East L Street Tacoma, Washington 98421 800-442-0438 U.S. Army Forensic Toxicology Drug Testing Laboratory 2490 Wilson St. Fort George G. Meade, MD 20755-5235 301-677-7085 * The Standards Council of Canada (SCC) voted to end its Laboratory Accreditation Program for Substance Abuse (LAPSA) effective May 12, 1998. Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation (DOT) regulations. As of that date, the [[Page 17444]] certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSA- accredited laboratories was transferred to the U.S. HHS, with the HHS' NLCP contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP may apply directly to the NLCP contractor just as U.S. laboratories do. Upon finding a Canadian laboratory to be qualified, HHS will recommend that DOT certify the laboratory (Federal Register, July 16, 1996) as meeting the minimum standards of the Mandatory Guidelines published in the Federal Register on April 30, 2010 (75 FR 22809). After receiving DOT certification, the laboratory will be included in the monthly list of HHS-certified laboratories and participate in the NLCP certification maintenance program. Janine Denis Cook, Chemist Division of Workplace Programs, Center for Substance Abuse Prevention, SAMHSA. [FR Doc. 2015-07423 Filed 3-31-15; 8:45 am] BILLING CODE 4162-20-P
![17442 Federal Register / Vol. 80, No. 62 / Wednesday, April 1, 2015 / Notices
competence of individual investigators, of Scientific Counselors, National Programs (Mandatory Guidelines). The
the disclosure of which would Advisory Neurological Disorders and Mandatory Guidelines were first
constitute a clearly unwarranted Stroke. published in the Federal Register on
invasion of personal privacy. The meeting will be closed to the April 11, 1988 (53 FR 11970), and
Name of Committee: Board of Scientific public as indicated below in accordance subsequently revised in the Federal
Counselors, NIA. with the provisions set forth in sections Register on June 9, 1994 (59 FR 29908);
Date: May 19, 2015. 552b(c)(6), Title 5 U.S.C., as amended September 30, 1997 (62 FR 51118);
Time: 8:00 a.m. to 8:30 a.m. for the review, discussion, and April 13, 2004 (69 FR 19644); November
Agenda: To review and evaluate personal evaluation of individual intramural 25, 2008 (73 FR 71858); December 10,
qualifications and performance, and programs and projects conducted by the 2008 (73 FR 75122); and on April 30,
competence of individual investigators. National Institute of Neurological
Place: National Institute on Aging,
2010 (75 FR 22809).
Biomedical Research Center, 3rd Floor
Disorders and Stroke, including A notice listing all currently HHS-
Conference Room, 251 Bayview Boulevard, consideration of personnel certified laboratories and IITFs is
Baltimore, MD 21224. qualifications and performance, and the published in the Federal Register
Open: 8:30 a.m. to 11:45 a.m. competence of individual investigators, during the first week of each month. If
Agenda: Committee discussion, individual the disclosure of which would any laboratory or IITF certification is
presentations, laboratory overview. constitute a clearly unwarranted suspended or revoked, the laboratory or
Place: National Institute on Aging, invasion of personal privacy. IITF will be omitted from subsequent
Biomedical Research Center, 3rd Floor
Conference Room, 251 Bayview Boulevard, Name of Committee: Board of Scientific lists until such time as it is restored to
Baltimore, MD 21224. Counselors, National Institute of full certification under the Mandatory
Closed: 11:45 a.m. to 12:45 p.m. Neurological Disorders and Stroke. Guidelines.
Agenda: To review and evaluate personal Date: May 17–19, 2015. If any laboratory or IITF has
qualifications and performance, and Time: 7:00 p.m. to 10:30 a.m. withdrawn from the HHS National
competence of individual investigators. Agenda: To review and evaluate personal Laboratory Certification Program (NLCP)
Place: National Institute on Aging, qualifications and performance, and
competence of individual investigators.
during the past month, it will be listed
Biomedical Research Center, 3rd Floor at the end and will be omitted from the
Conference Room, 251 Bayview Boulevard, Place: Residence Inn Bethesda, 7335
Baltimore, MD 21224. Wisconsin Avenue, Bethesda, MD 20814. monthly listing thereafter.
Open: 12:45 p.m. to 3:00 p.m. Contact Person: Alan P. Koretsky, Ph.D., This notice is also available on the
Agenda: Committee discussion, individual Scientific Director, Division of Intramural Internet at http://beta.samhsa.gov/
presentations, laboratory overview. Research, National Institute of Neurological workplace.
Place: National Institute on Aging, Disorders and Stroke, NIH, 35 Convent Drive,
Room 6A908, Bethesda, MD 20892, (301) FOR FURTHER INFORMATION CONTACT:
Biomedical Research Center, 3rd Floor
Conference Room, 251 Bayview Boulevard, 435–2232, koretskya@ninds.nih.gov. Giselle Hersh, Division of Workplace
Baltimore, MD 21224. (Catalogue of Federal Domestic Assistance
Programs, SAMHSA/CSAP, Room 7–
Closed: 3:00 p.m. to 4:00 p.m. Program Nos. 93.853, Clinical Research 1051, One Choke Cherry Road,
Agenda: To review and evaluate personal Related to Neurological Disorders; 93.854, Rockville, Maryland 20857; 240–276–
qualifications and performance, and Biological Basis Research in the 2600 (voice), 240–276–2610 (fax).
competence of individual investigators. Neurosciences, National Institutes of Health, SUPPLEMENTARY INFORMATION: The
Place: National Institute on Aging, HHS). Mandatory Guidelines were initially
Biomedical Research Center, 3rd Floor
Conference Room, 251 Bayview Boulevard, Dated: March 26, 2015. developed in accordance with Executive
Baltimore, MD 21224. Carolyn Baum, Order 12564 and section 503 of Pub. L.
Contact Person: Luigi Ferrucci, Ph.D., MD, Program Analyst, Office of Federal Advisory 100–71. The ‘‘Mandatory Guidelines for
Scientific Director, National Institute on Committee Policy. Federal Workplace Drug Testing
Aging, 251 Bayview Boulevard, Suite 100, [FR Doc. 2015–07342 Filed 3–31–15; 8:45 am] Programs,’’ as amended in the revisions
Room 4C225, Baltimore, MD 21224, 410– listed above, requires strict standards
BILLING CODE 4140–01–P
558–8110, LF27Z@NIH.GOV. that laboratories and IITFs must meet in
(Catalogue of Federal Domestic Assistance
order to conduct drug and specimen
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND validity tests on urine specimens for
HUMAN SERVICES federal agencies.
Dated: March 26, 2015. To become certified, an applicant
Melanie J. Gray, Substance Abuse and Mental Health laboratory or IITF must undergo three
Program Analyst, Office of Federal Advisory Services Administration rounds of performance testing plus an
Committee Policy. on-site inspection. To maintain that
[FR Doc. 2015–07337 Filed 3–31–15; 8:45 am] Current List of HHS-Certified certification, a laboratory or IITF must
BILLING CODE 4140–01–P
Laboratories and Instrumented Initial participate in a quarterly performance
Testing Facilities Which Meet Minimum testing program plus undergo periodic,
Standards To Engage in Urine Drug on-site inspections.
DEPARTMENT OF HEALTH AND Testing for Federal Agencies Laboratories and IITFs in the
HUMAN SERVICES AGENCY: Substance Abuse and Mental applicant stage of certification are not to
Health Services Administration, HHS. be considered as meeting the minimum
National Institutes of Health requirements described in the HHS
ACTION: Notice.
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institute of Neurological Mandatory Guidelines. A HHS-certified
SUMMARY: The Department of Health and laboratory or IITF must have its letter of
Disorders and Stroke; Notice of Closed
Human Services (HHS) notifies federal certification from HHS/SAMHSA
Meeting
agencies of the laboratories and (formerly: HHS/NIDA), which attests
Pursuant to section 10(d) of the Instrumented Initial Testing Facilities that it has met minimum standards.
Federal Advisory Committee Act, as (IITF) currently certified to meet the In accordance with the Mandatory
amended (5 U.S.C. App.), notice is standards of the Mandatory Guidelines Guidelines dated November 25, 2008
hereby given of a meeting of the Board for Federal Workplace Drug Testing (73 FR 71858), the following HHS-
VerDate Sep<11>2014 18:37 Mar 31, 2015 Jkt 235001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\01APN1.SGM 01APN1](https://thefederalregister.org/doc/80_FR_17504/page/1.svg)
![17444 Federal Register / Vol. 80, No. 62 / Wednesday, April 1, 2015 / Notices
certification of those accredited of ATSDR’s authority to prepare the most significant current potential
Canadian laboratories will continue toxicological profiles for substances not threat to human health. The availability
under DOT authority. The responsibility found at sites on the National Priorities of the revised list of the 275 priority
for conducting quarterly performance List. The agency will do so in order to substances was announced in the
testing plus periodic on-site inspections ‘‘. . . establish and maintain inventory Federal Register on May 28, 2014 (79
of those LAPSA-accredited laboratories of literature, research, and studies on FR 30613). For prior versions of the list
was transferred to the U.S. HHS, with the health effects of toxic substances’’ of substances, see Federal Register
the HHS’ NLCP contractor continuing to under CERCLA Section 104(i)(1)(B), to notices dated April 17, 1987 (52 FR
have an active role in the performance respond to requests for consultation 12866); October 20, 1988 (53 FR 41280);
testing and laboratory inspection under section 104(i)(4), and to support October 26, 1989 (54 FR 43619); October
processes. Other Canadian laboratories the site-specific response actions 17,1990 (55 FR 42067); October 17, 1991
wishing to be considered for the NLCP conducted by ATSDR, as otherwise (56 FR 52166); October 28, 1992 (57 FR
may apply directly to the NLCP necessary. 48801); February 28, 1994 (59 FR 9486);
contractor just as U.S. laboratories do. DATES: Nominations from the Substance April 29, 1996 (61 FR 18744); November
Upon finding a Canadian laboratory to Priority List and/or additional 17, 1997 (62 FR 61332); October 21,
be qualified, HHS will recommend that substances must be submitted within 30 1999 (64 FR 56792); October 25, 2001
DOT certify the laboratory (Federal days of the publication of this notice. (66 FR 54014); November 7, 2003 (68 FR
Register, July 16, 1996) as meeting the 63098); December 7, 2005 (70 FR
ADDRESSES: You may submit
minimum standards of the Mandatory 72840); and March 6, 2008 (73 FR
nominations, identified by Docket No.
Guidelines published in the Federal 12178); November 3, 2011 (76 FR
ATSDR–2015–0001, by any of the
Register on April 30, 2010 (75 FR 68193).
following methods:
22809). After receiving DOT
*Internet: Access the Federal Substances To Be Evaluated for Set 29
certification, the laboratory will be
eRulemaking portal at http:// Toxicological Profiles
included in the monthly list of HHS-
www.regulations.gov. Follow the Each year, ATSDR develops a list of
certified laboratories and participate in
instructions for submitting comments. substances to be considered for
the NLCP certification maintenance *Mail: Division of Toxicology and
program. toxicological profile development. The
Human Health Sciences, 1600 Clifton
Set 29 nomination process includes
Janine Denis Cook, Rd. NE., MS F–57, Atlanta, Ga., 30333.
Instructions: All submissions must consideration of all substances on
Chemist Division of Workplace Programs, ATSDR’s Priority List of Hazardous
Center for Substance Abuse Prevention, include the agency name and docket
number for this notice. All relevant Substances, also known as the
SAMHSA.
comments will be posted without Substance Priority List (SPL), as well as
[FR Doc. 2015–07423 Filed 3–31–15; 8:45 am]
other substances nominated by the
BILLING CODE 4162–20–P change. This means that no confidential
public. The 275 substances on the SPL
business information or other
will be considered for Set 29
confidential information should be
Toxicological Profile development. This
DEPARTMENT OF HEALTH AND submitted in response to this notice.
list may be found at the following Web
HUMAN SERVICES Refer to the section Submission of
site: www.atsdr.cdc.gov/SPL.
Nominations (below) for the specific
Agency for Toxic Substances and information required. Submission of Nominations for the
Disease Registry FOR FURTHER INFORMATION CONTACT: For Evaluation of Set 29 Proposed
[Docket No. ATSDR–2015–0001] further information, please contact Substances
Commander Jessilynn B. Taylor, Today’s notice invites voluntary
Proposed Substances To Be Evaluated Division of Toxicology and Human public nominations for substances
for Set 29 Toxicological Profiles Health Sciences, 1600 Clifton Rd. NE., included on the SPL and for substances
AGENCY: Agency for Toxic Substances MS F–57, Atlanta, Ga., 30333, Email: not listed on the SPL. All nominations
and Disease Registry (ATSDR), tpcandidatecomments@cdc.gov; phone: should include the full name of the
Department of Health and Human 1–800–232–4636. nominator, affiliation, and email
Services (HHS). SUPPLEMENTARY INFORMATION: The address. When nominating a non-SPL
ACTION: Request for comments on the
Superfund Amendments and substance, please include the rationale
proposed substances to be evaluated for Reauthorization Act of 1986 (SARA) [42 for the nomination. Please note that
Set 29 toxicological profiles. U.S.C. 9601 et seq.] amended the email addresses will not be posted on
Comprehensive Environmental regulations.gov.
SUMMARY: ATSDR is initiating the Response, Compensation, and Liability ATSDR will evaluate all data and
development of its 29th set of Act of 1980 (CERCLA or Superfund) [42 information associated with nominated
toxicological profiles (CERCLA Set 29). U.S.C. 9601 et seq.] by establishing substances and will determine the final
This notice announces the list of certain requirements for ATSDR and the list of substances to be chosen for
proposed substances that will be U.S. Environmental Protection Agency toxicological profile development.
evaluated for CERCLA Set 29 (EPA) with regard to hazardous Substances will be chosen according to
toxicological profile development. substances most commonly found at ATSDR’s specific guidelines for
ATSDR’s Division of Toxicology and facilities on the CERCLA National selection. These guidelines can be found
mstockstill on DSK4VPTVN1PROD with NOTICES
Human Health Sciences is soliciting Priorities List (NPL). Among these in the Selection Criteria announced in
public nominations from the list of statutory requirements is a mandate for the Federal Register on May 7, 1993 (58
proposed substances to be evaluated for the Administrator of ATSDR to prepare FR 27286–27287). A hard copy of the
toxicological profile development. toxicological profiles for each substance Selection Criteria is available upon
ATSDR also will consider the included on the Priority List of request or may be accessed at: http://
nomination of any additional, non- Hazardous Substances. This list www.atsdr.cdc.gov/toxprofiles/
CERCLA substances that may have identifies 275 hazardous substances that guidance/criteria_for_selecting_tp_
public health implications, on the basis ATSDR and EPA have determined pose support.pdf.
VerDate Sep<11>2014 18:37 Mar 31, 2015 Jkt 235001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\01APN1.SGM 01APN1](https://thefederalregister.org/doc/80_FR_17504/page/3.svg)
Document Created: 2015-12-18 11:04:52
Document Modified: 2015-12-18 11:04:52
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Contact | Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, Room 7-1051, One Choke Cherry Road, Rockville, Maryland 20857; 240-276-2600 (voice), 240-276-2610 (fax). | |
| FR Citation | 80 FR 17442 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR